FDA Approved Products

1,302 products with lifecycle intelligence, competitive pressure scores, and patent timelines.

Type:AllNDABLAANDA
Lifecycle:GrowthPeakLOE ApproachingPost-LOELaunchPre-Launch
Sort:Approval DateNameCompetitive Pressure↓
Active:Lifecycle: PeakClear all
NEXLIZET
bempedoic acid and ezetimibe
Peak
ORAL · TABLET
2020
NDA
0/100
NEXTSTELLIS
drospirenone and estetrol
Peak
ORAL · TABLET
2021
NDA
0/100
NITHIODOTE
sodium nitrite and sodium thiosulfate
Peak
Hope Pharmaceuticals
INTRAVENOUS, INTRAVENOUS · SOLUTION, SOLUTION
acute cyanide poisoninglife-threatening
2011
NDA
0/100
NITYR
nitisinone
Peak
ORAL · TABLET
2017
NDA
0/100
NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE
norepinephrine bitartrate
Peak
Baxter
INTRAVENOUS · SOLUTION
2021
NDA
0/100
NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE
norepinephrine bitartrate
Peak
INTRAVENOUS · SOLUTION
2022
NDA
0/100
NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE
norepinephrine bitartrate
Peak
INTRAVENOUS · SOLUTION
2022
NDA
0/100
NOREPINEPHRINE BITARTRATE IN 5% DEXTROSE
norepinephrine bitartrate
Peak
Baxter
INTRAVENOUS · SOLUTION
2021
NDA
0/100
NORLIQVA
amlodipine
Peak
ORAL · SOLUTION
2022
SMNDA
0/100
NOURESS
cysteine hydrochloride
Peak
Baxter
INTRAVENOUS · SOLUTION
2019
NDA
0/100
NOXAFIL
posaconazole
Peak
Merck & Co.
INTRAVENOUS · SOLUTION
invasive aspergillosisolder+11
2014
SMNDA
0/100
NUBEQA
darolutamide
Peak
Bayer
ORAL · TABLET
prostate cancer
2019
NDA
0/100
NUMBRINO
cocaine hydrochloride nasal
Peak
NASAL · SOLUTION
2020
NDA
0/100
NUPLAZID
pimavanserin tartrate
Peak
Acadia Pharmaceuticals
ORAL · TABLET
hallucinationsdelusions associated with Parkinson's disease psychosis
2016
NDA
0/100
NUPLAZID
pimavanserin tartrate
Peak
Acadia Pharmaceuticals
ORAL · CAPSULE
hallucinationsdelusions associated with Parkinson's disease psychosis
2018
NDA
0/100
NURTEC ODT
rimegepant sulfate
Peak
Pfizer
ORAL · TABLET, ORALLY DISINTEGRATING
migraine
2020
NDA
0/100
NUVESSA
metronidazole
Peak
VAGINAL · GEL
bacterial vaginosis in females 12 years of ageolder
2014
SMNDA
0/100
NUZYRA
omadacycline
Peak
Paratek Pharmaceuticals
ORAL · TABLET
Staphylococcus aureus (methicillin-susceptible isolates)Haemophilus influenzae+10
2018
SMNDA
0/100
NUZYRA
omadacycline
Peak
Paratek Pharmaceuticals
INTRAVENOUS · POWDER
Staphylococcus aureus (methicillin-susceptible isolates)Haemophilus influenzae+10
2018
SMNDA
0/100
NYMALIZE
nimodipine
Peak
R-Pharm US
ORAL · SOLUTION
2013
SMNDA
0/100
OBREDON
guaifenesin; hydrocodone bitartrate
Peak
ORAL · SOLUTION
2014
NDA
0/100
OCALIVA
obeticholic acid
Peak
ORAL · TABLET
2016
NDA
0/100
ODEFSEY
emtricitabine, rilpivirine hydrochloride, and tenofovir alafenamide
Peak
Gilead Sciences
ORAL · TABLET
2016
NDA
0/100
ODOMZO
sonidegib
Peak
Fosun Pharma
ORAL · CAPSULE
radiation therapythose
2015
NDA
0/100
← PreviousPage 41 of 55Next →